 |
|
|
|
Media Center Overview
|
|
|
An Evening Symposium held during the European Respiratory Society Annual Congress 2005, Copenhagen
Protease – Antiprotease revisited
We would be happy welcoming you at the symposium. See you again in Copenhagen in September
Sunday, September 18, 2005
Evening Symposium 17:15 to 19:15
Bella Centre, Copenhagen
Conference Room 18–19
17:15–17:20 Welcome and Introduction
Claus Vogelmeier, Marburg, Germany
17:20–17:40
Meta-analysis of clinical data for Alpha1-Antitrypsin inhibitor
Kenneth Chapman, Toronto, Canada
17:40–17:55
Alpha1-Antitrypsin mechanisms
David A. Lomas, Cambridge, UK
17:55–18:10
Genetic risk for AATD patients to develop lung disease
Ed Silverman, Boston, USA
18:10–18:30
Alpha1-Antitrypsin deficiency and infection
Robert Stockley, Birmingham, UK
18:30–18:45
Spread – CT scan study
Jan Stolk, Leiden,The Netherlands
18:45–18:50
Association between plasma Alpha1- Antitrypsin concentration and 11-year course of lung function among adult smokers in the SAPALDIA cohort – brief report of the results
Oliver Senn, Zurich, Switzerland
18:50–18:55
Chaperone based therapy of Alpha1-Antitrypsin deficiency in a smokeinduced murine model of emphysema – brief report of the results
Robert Bals, Marburg, Germany
18:55–19:05
Laudation,Award
Bernhard Schaefer, RTP, USA
19:05–19:15
Laureates NN
|
|
|
|
|
|
|
|
